From October 1, 2022 to December 31, 2022, the company has repurchased 130,000 shares, representing 0.03% for CNY 1.06 million. With this, the company has completed the repurchase of 6,430,000 shares, representing 1.31% for CNY 61.05 million under the buyback announced on May 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.04 CNY | -0.74% | -7.59% | +9.09% |
04-25 | Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Guangdong VTR Bio-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.09% | 537M | |
+16.90% | 12.26B | |
+1.93% | 6.04B | |
+6.97% | 5.37B | |
+13.27% | 4.96B | |
-20.30% | 2.74B | |
+3.62% | 1.92B | |
-15.20% | 1.28B | |
-10.63% | 958M | |
-20.72% | 957M |
- Stock Market
- Equities
- 300381 Stock
- News Guangdong VTR Bio-Tech Co., Ltd.
- Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022.